Gallen International Breast Cancer Conference divided breast cancer into several molecular subtypes based on the expression of hormone receptors (ER, PR), HER2 status, and proliferation markers such as Ki-67 [19]. This evidence concerns the gene MKI67 and breast carcinoma.